Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.49 - $0.61 $2,112 - $2,630
-4,312 Reduced 1.3%
328,111 $200,000
Q2 2022

Aug 12, 2022

SELL
$0.38 - $0.89 $533,659 - $1.25 Million
-1,404,367 Reduced 80.86%
332,423 $269,000
Q1 2022

May 13, 2022

SELL
$0.58 - $0.86 $35,073 - $52,005
-60,472 Reduced 3.36%
1,736,790 $1.05 Million
Q4 2021

Feb 08, 2022

BUY
$0.73 - $1.28 $976 - $1,712
1,338 Added 0.07%
1,797,262 $1.47 Million
Q3 2021

Nov 15, 2021

BUY
$0.77 - $4.91 $83,762 - $534,119
108,782 Added 6.45%
1,795,924 $1.42 Million
Q2 2021

Aug 13, 2021

BUY
$2.18 - $4.66 $3.03 Million - $6.47 Million
1,387,689 Added 463.41%
1,687,142 $7.79 Million
Q1 2021

May 12, 2021

BUY
$1.3 - $3.24 $83,785 - $208,818
64,450 Added 27.43%
299,453 $779,000
Q4 2020

Feb 11, 2021

SELL
$1.01 - $1.77 $2,377 - $4,166
-2,354 Reduced 0.99%
235,003 $317,000
Q3 2020

Nov 16, 2020

BUY
$0.67 - $1.4 $9,805 - $20,489
14,635 Added 6.57%
237,357 $332,000
Q1 2020

May 14, 2020

BUY
$0.39 - $1.03 $22,103 - $58,375
56,675 Added 34.13%
222,722 $125,000
Q4 2019

Feb 14, 2020

SELL
$0.89 - $1.5 $3,560 - $6,001
-4,001 Reduced 2.35%
166,047 $173,000
Q3 2019

Nov 13, 2019

BUY
$1.04 - $1.51 $41,264 - $59,912
39,677 Added 30.43%
170,048 $199,000
Q2 2019

Aug 13, 2019

BUY
$0.95 - $2.46 $916 - $2,373
965 Added 0.75%
130,371 $195,000
Q1 2019

May 13, 2019

SELL
$0.69 - $1.47 $22,912 - $48,812
-33,206 Reduced 20.42%
129,406 $133,000
Q4 2018

Feb 12, 2019

SELL
$0.96 - $2.04 $464 - $987
-484 Reduced 0.3%
162,612 $231,000
Q3 2018

Nov 14, 2018

BUY
$1.54 - $2.38 $2,836 - $4,383
1,842 Added 1.14%
163,096 $350,000
Q2 2018

Sep 18, 2018

BUY
$1.04 - $3.29 $30,710 - $97,150
29,529 Added 22.42%
161,254 $315,000
Q2 2018

Aug 14, 2018

BUY
$1.04 - $3.29 $136,994 - $433,375
131,725 New
131,725 $257,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Sesen Bio, Inc.


  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.